Skip to main content
Clinical Trials/NCT05484947
NCT05484947CompletedNot Applicable

The HIV Testing Trends and Outcomes at a Johannesburg Trauma ICU Unit

University of Witwatersrand, South Africa1 site in 1 country868 target enrollmentStarted: January 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
868
Locations
1
Primary Endpoint
Outcomes

Study Overview

Brief Summary

A retrospective observational study on the HIV testing trend and outcomes in a trauma population admitted to a critical care unit for care.

Detailed Description

Trauma ICU admission of 18 years and older were enrolled in the study. The HIV status was further divided into HIV-positive, HIV-negative, and HIV-unknown subgroups. The gender, ages, mechanism of injury, injuries sustained, ISS, physiological data, septic-related complications, and in-hospital mortality were noted and further analyzed.

Descriptive statistics were utilised using STATA version 15, and a p-value of <0.05 was considered statistically significant.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Trauma patients admitted to a Trauma ICU at CMJAH -

Exclusion Criteria

  • •Those under the age of 18 or with incomplete data

Outcomes

Primary Outcomes

Outcomes

Time Frame: study period over two years (from 01 January 2017 till 31 December 2018)

Septic related complications (wound infections, chest sepsis, septicaemia and sepsis related organ failure incidents

The HIV testing trends

Time Frame: study period over two years (from 01 January 2017 till 31 December 2018)

Number tested for HIV in the study group

Secondary Outcomes

  • Mortality(study period over two years (from 01 January 2017 till 31 December 2018))

Investigators

Sponsor
University of Witwatersrand, South Africa
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Maeyane Stephens Moeng

Professor

University of Witwatersrand, South Africa

Study Sites (1)

Loading locations...

Similar Trials